{
    "Trade/Device Name(s)": [
        "ONLINE TDM Vancomycin Gen.3"
    ],
    "Submitter Information": "Roche Diagnostics Operations (RDO)",
    "510(k) Number": "K152245",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060586"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LEH"
    ],
    "Summary Letter Date": "December 9, 2015",
    "Summary Letter Received Date": "December 10, 2015",
    "Submission Date": "July 31, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3950"
    ],
    "Regulation Name(s)": [
        "Vancomycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501"
    ],
    "Method(s)/Technology(ies)": [
        "Microparticle agglutination immunoassay",
        "Kinetic interaction of microparticles in solution (KIMS)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Homogeneous competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ONLINE TDM Vancomycin Gen.3 assay for quantitative determination of vancomycin in serum and plasma on Roche/Hitachi cobas c systems using KIMS technology",
    "Indications for Use Summary": "In vitro test for quantitative determination of vancomycin in serum and plasma to aid in diagnosis and treatment of vancomycin overdose and monitoring vancomycin therapy",
    "fda_folder": "Toxicology"
}